HSAS1 人皮膚成纖維細(xì)胞
Catalogue No.: C1312
Product Format: a T25 flask
Culture Properties：貼壁
Complete Growth Medium: 89%H-DMEM+10%FBS+1%雙抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.

Components

increase tumor specific immunity. Maintenance therapies including Immunomodulatory drukl, proteasome inhibitors and daratumumab exhibit a significant anti myeloma response by modulating the immune system. Lenalidomide promotes an anti-tumoral immune microenvironment, while daratumumab can potentially cause NK cell fratricide. Hence understanding the effects of commonly used maintenance drukl on the immune system